CILIARY BLUE LIMITED

1. Financial Health Score: F (Terminal)

This business is in a state of financial failure. The patient has succumbed to a chronic liquidity crisis, evidenced by a complete depletion of cash reserves and an inability to meet short-term debts. Furthermore, the company’s current status in "Liquidation" confirms that the business has ceased to function, and its remaining vital signs are merely being administered by a liquidator for the purpose of closing the estate.

2. Key Vital Signs

• Pulse (Cash Position): Flatline. As of the last filed accounts (October 2015), the company had £0 in the bank, down from a meagre £443 the previous year. A business without cash is like a patient without a pulse—unable to survive without external life support.
• Blood Pressure (Liquidity): Dangerously Hypertensive. Current liabilities (£192,623) heavily outweigh any immediate liquidity. While the company shows £231,674 in current assets (primarily debtors), the absolute lack of cash means the business is suffering from severe financial "blockage," unable to convert money owed into money in hand to pay urgent bills.
• Weight Loss (Equity Erosion): Emaciated. The business has been steadily losing financial mass. Shareholders' funds dropped from £86,403 in 2012 to £42,720 in 2014, and down to £31,683 by 2015. The Profit and Loss reserve shows a haemorrhage of £11,037 during the 2015 financial year alone, indicating the business was bleeding money.
• Temperature (Filing Compliance): Feverish and Neglected. The company’s accounts are significantly overdue (last filed for 2015), and the confirmation statement is also overdue. This level of administrative neglect is a classic symptom of a business that has lost the capacity or willingness to maintain basic corporate hygiene.
• Reflexes (Company Status): Unresponsive. The company status is officially listed as "Liquidation," meaning the corporate body is no longer operating as a going concern.

3. Diagnosis

The financial data reveals a business suffering from a terminal liquidity crisis. While Ciliary Blue Limited operated in the human health activities sector, it failed to maintain its own financial health.

The core pathology was an over-reliance on debtors (money owed by others) to sustain the business. With £231,674 tied up in debtors and zero cash in the bank, the business was entirely dependent on the timely payment of those invoices to service its £192,623 in short-term debts. When those payments stalled or the cash cycle broke, the business suffered a fatal cardiac arrest.

The steady deterioration of net assets over the years—from £86,403 in 2012 down to £31,683 in 2015—shows a chronic, underlying illness where the cost of doing business and servicing debt consistently outpaced income. The transition into liquidation is the inevitable conclusion of a business that could not convert its receivables into the lifeblood of cash quickly enough to survive.

4. Recommendations

Because the company is in Liquidation, standard prescriptions for financial recovery (such as refinancing or restructuring) are no longer viable. The focus must shift from resuscitation to a controlled post-mortem:

• Cooperate with the Liquidator: The directors (Mr. and Xxxxxx Xxxxxxxxname shown to subscribers) must ensure a full and transparent handover of all books, records, and company assets to the appointed liquidator. This is akin to providing a complete medical history to the coroner.
• Maximize Asset Realization: The primary remaining asset is the £231,674 in debtor balances. Every effort must be made by the liquidator to collect these debts to satisfy the £192,623 in current liabilities.
• Director Conduct Review: Directors should ensure their conduct leading up to the liquidation is beyond reproach to avoid potential disqualification orders or personal liability for wrongful trading.
• Cease All Activity: No further trading, debt accumulation, or financial commitments should be undertaken under this corporate entity.

Names of the people mentioned are shown to subscribers. See subscription